(Reuters) -Swiss medical technology company Ypsomed is planning to move some production to Germany and increase its output in the U.S. due to the threat of 39% tariffs on imports from Switzerland, Bloomberg News reported on Tuesday, citing its CEO Simon Michel.
(Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Sahal Muhammed)
